David K. Herron

Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain

J. Scott Sawyer, Bryan D. Anderson, Douglas W. Beight et al. · Journal of Medicinal Chemistry · 2003 · 237 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Alpha- and beta-adrenergic induction of the expression of the uncoupling protein thermogenin in brown adipocytes differentiated in culture.

Stefan Rehnmark, M. Nechad, David K. Herron et al. · Journal of Biological Chemistry · 1990 · 201 citations · Full text

Life Sciences, Cell Biology, Physiology +15

Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain

J. Scott Sawyer, Douglas W. Beight, Karen S. Britt et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 163 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Induction and degradation of the uncoupling protein thermogenin in brown adipocytes <i>in vitro</i> and <i>in vivo</i>. Evidence for a rapidly degradable pool

Pere Puigserver, David K. Herron, Magdalena Gianotti et al. · Biochemical Journal · 1992 · 107 citations · Full text

Life Sciences, Biochemistry, Physiology +12

Kinetic Characterization of Novel Pyrazole TGF-β Receptor I Kinase Inhibitors and Their Blockade of the Epithelial−Mesenchymal Transition

Sheng-Bin Peng, Lei Yan, Xiaoling Xia et al. · Biochemistry · 2005 · 99 citations

Life Sciences, Cell Biology, Pharmacology +14